Loading clinical trials...
Loading clinical trials...
Effectiveness of Low-doses of Naltrexone (LDN) on Pain Perception and Quality of Life in Women With Vulvodynia
Conditions
Interventions
Naltrexone Hydrochloride
Locations
1
Poland
Terpa Limited Liability Company Limited Partnership
Lublin, Poland
Start Date
May 31, 2023
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2026
Last Updated
July 21, 2023
NCT05883540
NCT07546435
NCT07257029
NCT07444697
NCT04499326
NCT06819592
Lead Sponsor
Medical University of Lublin
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions